Last reviewed · How we verify

NCT05281640: PICASSO

Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial

Completed NA Last updated 23 February 2024
What this trial tests

NA trial testing Affect Dysregulation intervention in Psychosis in 57 participants. Completed in 31 August 2023.

Timeline
28 February 2022
Primary endpoint
31 August 2023
31 August 2023

Quick facts

Lead sponsorEdinburgh Napier University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment57
Start date28 February 2022
Primary completion31 August 2023
Estimated completion31 August 2023
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Edinburgh Napier University

Who can join

Adults 18 to 65, any sex, with Psychosis or Complex Post-Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Psychosis is a highly distressing mental health condition, affecting up to 3% of the population. Conceptually, it has much in common with complex post-traumatic stress disorder (CPTSD), a recently introduced condition in ICD-11. Both involve negative self-esteem, impaired emotion regulation ability, interpersonal difficulties and intrusive trauma- related experiences (i.e. intrusive thoughts, flashbacks, nightmares). Both have been causally related to childhood trauma, such as abuse, neglect and loss. The current project will examine the feasibility of conducting an 'Umbrella trial' to test whether CPTSD is causally related to psychosis, and develop more effective trauma-focused psychological interventions for psychotic symptoms by treating underlying experiences of/reactions to trauma. An Umbrella trial involves running several individual randomised controlled trials concurrently. In this study, each trial will test whether psychological interventions designed to reduce different CPTSD symptoms cause improvements in psychotic symptoms. If the investigators can establish feasibility of this Umbrella trial, and if a definitive version shows that interventions for CPTSD also reduce psychosis, then this would be a breakthrough in both the conceptualisation and treatment of psychosis which will help transform the care of people with psychosis. Demonstrating the feasibility of our proposed methodology would also help to accelerate the development of interventions for other mental health problems.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Trauma-Focused Treatment in Early and Lifetime Psychosis: A Scoping Review.
    Jankowski SE, Bennett R, Tao B, Neria Y, et al · · 2025 · PMID 41275365 · DOI 10.1093/schbul/sbaf202

Verify or expand the search:

Other recruiting trials for Psychosis

Currently open trials in the same condition.

Other Edinburgh Napier University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05281640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing